All Stories

  1. COPD Trial Evidence Comes from a Narrow Slice of the World: A Population Representativeness Analysis.
  2. Kounis Syndrome Features in Special Populations
  3. Impact of older age on prognosis in hypersensitivity pneumonitis: A systematic review and meta‑analysis
  4. COPD and kidney disease: not so far apart?
  5. Assessment of Comorbidities in Chronic Obstructive Pulmonary Disease Patients by Chest High Resolution Computed Tomography (HRCT)
  6. A deep dive into atrial fibrillation in chronic obstructive pulmonary disease
  7. Assessment of Comorbidities in Chronic Obstructive Pulmonary Disease Patients by Chest High Resolution Computed Tomography (HRCT)
  8. Ensuring patient safety: a closer look at glucocorticoid therapy in COPD and asthma
  9. COPD and Cardiovascular Diseases: Biomarker-Guided Stratification and Therapeutic Perspectives
  10. Clinical and immunological assessment of thyroid pathology in rheumatoid arthritis
  11. Global burden of lower respiratory infections and aetiologies, 1990–2023: a systematic analysis for the Global Burden of Disease Study 2023
  12. Patients with sickle cell disease and asthma have a higher risk for acute chest syndrome: A systematic review and meta‑analysis of observational studies
  13. Impact of urogenital and enterocolitic infections on the onset and evolution of ankylosing spondylitis and psoriatic arthritis
  14. Chronic obstructive pulmonary disease (COPD) and autoimmune diseases: unravelling complex interactions
  15. The Hidden Burden of COMISA: Clinical Implications and Treatment Challenges
  16. Burden of ophthalmologic disorders in obstructive sleep apnea
  17. Diagnostic and management controversies in ANCA-associated interstitial lung diseases
  18. Fungal allergy - features of molecular diagnosis
  19. Cardiopulmonary exercise testing in chronic obstructive pulmonary disease
  20. Burden of 375 diseases and injuries, risk-attributable burden of 88 risk factors, and healthy life expectancy in 204 countries and territories, including 660 subnational locations, 1990–2023: a systematic analysis for the Global Burden of Disease Study...
  21. Global burden of 292 causes of death in 204 countries and territories and 660 subnational locations, 1990–2023: a systematic analysis for the Global Burden of Disease Study 2023
  22. Potential of doxofylline in the treatment of chronic obstructive airway diseases (Review)
  23. The impact of comorbidities on chronic obstructive pulmonary disease
  24. Tuberculosis in new cases: the impact of HIV status on clinical manifestations
  25. Comparative analysis of clinical characteristics of gout patients
  26. Chronic Obstructive Pulmonary Disease and Depression—The Vicious Mental Cycle
  27. Anti-reflux therapy and mortality in patients with idiopathic pulmonary fibrosis and gastroesophageal reflux disease: a systematic review and meta-analysis
  28. Broad Electrocardiogram Syndromes Spectrum: From Common Emergencies to Particular Electrical Heart Disorders—Part II
  29. Diurnal variation in spirometry parameters of patients with chronic obstructive pulmonary disease: A systematic review and meta‑analysis
  30. Global, regional, and national trends in routine childhood vaccination coverage from 1980 to 2023
  31. Metabolic storm in psoriatic arthritis: a cardiovascular time bomb?
  32. Diagnostic tools in respiratory medicine (Review)
  33. COPD and Depression—The Vicious Mental Cycle
  34. Global, regional, and national burden of asthma and atopic dermatitis, 1990–2021, and projections to 2050: a systematic analysis of the Global Burden of Disease Study 2021
  35. Weltweite Perspektiven von Krankenhauspatienten zum Einsatz von künstlicher Intelligenz im Gesundheitswesen: Ergebnisse der COMFORT-Studie aus 74 Krankenhäusern in 43 Ländern
  36. Challenges of Pediatric Tuberculosis Under Current Conditions
  37. Forecasting the effects of smoking prevalence scenarios on years of life lost and life expectancy from 2022 to 2050: a systematic analysis for the Global Burden of Disease Study 2021
  38. Global cross-sectional student survey on AI in medical, dental, and veterinary education and practice at 192 faculties
  39. Assessment of comorbidities in COPD patients by chest HRCT
  40. Endobronchial foreign bodies in pediatric work – history and clinical signs suggestive of diagnosis
  41. Sarcoidosis and cancer - a diagnostic dilema
  42. Multinational attitudes towards AI in healthcare and diagnostics among hospital patients
  43. Global, regional, and national burden of upper respiratory infections and otitis media, 1990–2021: a systematic analysis from the Global Burden of Disease Study 2021
  44. Cardio-psycho-metabolic profile of patients with cardiovascular disease and obesity
  45. Particularities of comorbidities in nonalcoholic fatty liver disease according to gender groups
  46. Global burden and strength of evidence for 88 risk factors in 204 countries and 811 subnational locations, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021
  47. Editorial: Treatment of comorbidities of asthma and its safety
  48. Inhaledversussystemic corticosteroids for acute exacerbations of COPD: a systematic review and meta-analysis
  49. Hypersensitivity Pneumonitis: Challenges of a Complex Disease
  50. Medical students’ perceptions towards artificial intelligence in education and practice: A multinational, multicenter cross-sectional study
  51. Israel−Palestine Conflict: Risk of Sleep Disorders and Post-Traumatic Stress Disorders
  52. Promising treatment biomarkers in asthma
  53. Complications of tracheobronchial foreign body aspiration in children
  54. Phenotypes in adult patients with bronchiectasis: a cluster analysis
  55. The Burden of Comorbidities in Obstructive Sleep Apnea
  56. Combined Pulmonary Fibrosis and Emphysema: Comparative Evidence on a Complex Condition
  57. Prevalence and Burden of Comorbidities in Obstructive Sleep Apnea Syndrome
  58. Characterisation of the Antibody Response in Sinopharm (BBIBP-CorV) Recipients and COVID-19 Convalescent Sera from the Republic of Moldova
  59. Updates in screening for tuberculosis. Review of guidelines
  60. Diagnostic challenges of a rare disease with an unusual presentation
  61. Peripheral neuropathy: A neglected cause of disability in COPD – A narrative review
  62. Predictors of the Efficacy for Daytime Sleepiness in Patients With Obstructive Sleep Apnea With Continual Positive Airway Pressure Therapy: A Meta-Analysis of Randomized Controlled Trials
  63. COPD and Diabetes Mellitus: Down the Rabbit Hole
  64. Scientists Against War: A Plea to World Leaders for Better Governance
  65. COPD and comorbidities in the Republic of Moldova
  66. Management of COVID-19-Associated Acute Respiratory Failure with Alternatives to Invasive Mechanical Ventilation: High-Flow Oxygen, Continuous Positive Airway Pressure, and Noninvasive Ventilation
  67. Asthma and obstructive sleep apnoea in adults and children – an up-to-date review
  68. ERS statement: a core outcome set for clinical trials evaluating the management of COPD exacerbations
  69. Screening, Diagnostic and Prognostic Tests for COVID-19: A Comprehensive Review
  70. The association between beta-blocker therapy and daytime sleepiness in obstructive sleep apnoea
  71. Multidimensional indices in the assessment of chronic obstructive pulmonary disease
  72. Asthma-COPD Overlap: A more Simplistic Approach
  73. Chronic obstructive disease and comorbidities (literature review)
  74. Current Approaches to Asthma In 2021
  75. A rare case of intrathymic epidermoid cyst
  76. Asthma and stroke: a narrative review
  77. Adenoid hypertrophy can impact craniofacial growth and lead to obstructive sleep apnea in children
  78. Coenzyme Q10 suplement in chronic obstructive pulmonary disease
  79. Efficiency of different multidimensional indexes for the assessment of the risk of exacerbations in patients with COPD
  80. The DisEntangling Chronic Obstructive pulmonary Disease Exacerbations clinical trials NETwork (DECODE-NET): rationale and vision
  81. Core outcome set for the management of acute exacerbations of chronic obstructive pulmonary disease: the COS-AECOPD ERS Task Force study protocol
  82. Alpha-1 Antitrypsin Deficiency and Chronic Obstructive Pulmonary Disease: Between Overlaps, Phenotypes and Illnesses
  83. Current Approaches to COPD in 2019
  84. “Chronic obstructive pulmonary disease and phenotypes: a state-of-the-art.”
  85. Spontaneous Pneumomediastinum – a Rare Asthma Complication
  86. Efficiency of different approaches for the assessment of the risk of exacerbations in patients with COPD
  87. Identification of clinical phenotypes using cluster analyses in COPD patients
  88. Achieving Thoracic Oncology data collection in Europe: a precursor study in 35 Countries
  89. A MULTILATERAL APPROACH TO COPD COMORBIDITIES
  90. EARLY versus MILD Chronic Obstructive Pulmonary Disease (COPD)
  91. COPD and Stroke
  92. Health-related quality of life in different phenotypes of COPD
  93. Assessment of health-related quality of life in different phenotypes of COPD
  94. Bode index in different phenotypes of COPD
  95. To sleep, or not to sleep?
  96. ACOS: current evidence and future research directions
  97. Phenotyping Before Starting Treatment in COPD?
  98. Procalcitonin to guide antibiotic administration in COPD exacerbations: a meta-analysis
  99. Exercise-Induced Pulmonary Edema in Athletes
  100. Editorial: "COPD: More than a Moving Target!"
  101. P51 Clinical effectiveness of procalcitonin based protocols to guide the administration of antibiotics in patients presenting with COPD exacerbations: systematic review and meta-analysis
  102. Prevalence and burden of comorbidities in COPD
  103. Meet Our Assistant Editor
  104. Overview of the translocation of rupestrian ferruginous fields of Capão Xavier mine to the Serra do Rola Moça State Park, Minas Gerais – Brazil
  105. Editorial: Continuous Positive Airway Pressure: Life-Saving Technology
  106. Health-Related Quality of Life in Patients with COPD
  107. Obstructive Sleep Apnea and Hypertension: A Bidirectional Causal Relation
  108. Obstructive Sleep Apnea and Type 2 Diabetes: Dual Interaction
  109. Overlap Syndrome of Chronic Obstructive Pulmonary Disease and Obstructive Sleep Apnoea
  110. Editorial from Guest Editor: Current Management of Sleep Apnea and Comorbidities
  111. COPD Phenotypes and Biomarkers: Introducing Personalised Medicine
  112. Management of Stable COPD: An Update
  113. Breast cancer local recurrence under the form of inflammatory carcinoma, treated with concurrent radiation and chemotherapy, a case report
  114. Defining COPD
  115. Imaging for diagnosis and management of tuberculosis